Quick Answer
SILICON LABORATORIES INC. reported Total Revenue of $784.76 million for fiscal year 2025.
SILICON LABORATORIES INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $784.76M +34.3% |
$584.39M -25.3% |
$782.26M -23.6% |
$1.02B +42.1% |
$720.86M +41.1% |
$510.93M +7.8% |
| Revenue (ASC 606) | $784.76M +34.3% |
$584.39M -25.3% |
$782.26M -23.6% |
$1.02B +42.1% |
$720.86M +41.1% |
$510.93M +7.8% |
| Net Income | -$64.91M +66.0% |
-$191.01M -453.4% |
-$34.52M | — | — | — |
| Diluted EPS | -$1.98 +66.6% |
-$5.93 -444.0% |
-$1.09 -142.9% |
$2.54 -94.7% |
$47.78 +16964.3% |
$0.28 -34.9% |
| Total Assets | $1.27B +3.8% |
$1.22B -15.3% |
$1.44B -33.5% |
$2.17B -26.7% |
$2.96B +48.4% |
$1.99B +19.0% |
| Cash and Equivalents | $364.22M +29.3% |
$281.61M +23.8% |
$227.50M -54.5% |
$499.92M -53.5% |
$1.07B +430.1% |
$202.72M -10.8% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $1.09B +1.3% |
$1.08B -10.6% |
$1.21B -14.0% |
$1.41B -36.5% |
$2.21B +84.4% |
$1.20B +7.6% |
| R&D Expense | $353.25M +6.3% |
$332.23M -1.6% |
$337.74M +1.6% |
$332.33M +21.6% |
$273.21M +16.2% |
$235.19M +14.3% |
| Operating Income | -$70.54M +57.4% |
-$165.49M -585.1% |
-$24.15M -120.3% |
$119.26M +463.2% |
-$32.84M +69.3% |
-$107.09M -20.8% |
| Gross Profit | $456.98M +46.4% |
$312.19M -32.2% |
$460.59M -28.3% |
$642.56M +51.1% |
$425.39M +44.3% |
$294.85M +5.2% |
| Shares Outstanding | 32.95M +1.5% |
32.46M +1.8% |
31.90M -0.3% |
31.99M -16.9% |
38.48M -12.4% |
43.92M +1.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $206.00M | +23.8% | +6.8% |
| Revenue (ASC 606) | September 30, 2025 | $206.00M | +23.8% | +6.8% |
| Net Income | September 30, 2025 | -$9.94M | +65.1% | +54.5% |
| Diluted EPS | September 30, 2025 | -$0.30 | +65.9% | +55.2% |
| Total Assets | September 30, 2025 | $1.25B | +0.3% | +2.6% |
| Cash and Equivalents | September 30, 2025 | $341.40M | +12.6% | +8.6% |
| Long-Term Debt | December 31, 2016 | $72.50M | +7.4% | +0.0% |
| Stockholders Equity | September 30, 2025 | $1.07B | -1.0% | +0.9% |
| R&D Expense | September 30, 2025 | $87.69M | +5.4% | -0.2% |
| Operating Income | September 30, 2025 | -$12.34M | +58.5% | +46.0% |
| Gross Profit | September 30, 2025 | $119.02M | +31.8% | +10.1% |
| Shares Outstanding | September 30, 2025 | 32.85M | +1.6% | +0.1% |
- SILICON LABORATORIES INC. reported Total Revenue of $784.76 million for fiscal year 2025.
- SILICON LABORATORIES INC. showed an increase of +34.3% in Total Revenue compared to the prior fiscal year.
- SILICON LABORATORIES INC. reported Revenue (ASC 606) of $784.76 million for fiscal year 2025.
- SILICON LABORATORIES INC. showed an increase of +34.3% in Revenue (ASC 606) compared to the prior fiscal year.
- SILICON LABORATORIES INC. reported Net Income of -$64.91 million for fiscal year 2025.
- SILICON LABORATORIES INC. showed an increase of +66.0% in Net Income compared to the prior fiscal year.
- SILICON LABORATORIES INC. reported Diluted EPS of $1.98 per share (loss) for fiscal year 2025.
- SILICON LABORATORIES INC. showed an increase of +66.6% in Diluted EPS compared to the prior fiscal year.
- SILICON LABORATORIES INC. reported Total Assets of $1.27 billion for fiscal year 2025.
- SILICON LABORATORIES INC. showed an increase of +3.8% in Total Assets compared to the prior fiscal year.
- SILICON LABORATORIES INC. reported Cash and Equivalents of $364.22 million for fiscal year 2025.
- SILICON LABORATORIES INC. showed an increase of +29.3% in Cash and Equivalents compared to the prior fiscal year.
- SILICON LABORATORIES INC. reported Long-Term Debt of $72.50 million for fiscal year 2016.
- SILICON LABORATORIES INC. showed an increase of +7.4% in Long-Term Debt compared to the prior fiscal year.
- SILICON LABORATORIES INC. reported Stockholders Equity of $1.09 billion for fiscal year 2025.
- SILICON LABORATORIES INC. showed an increase of +1.3% in Stockholders Equity compared to the prior fiscal year.
- SILICON LABORATORIES INC. reported R&D Expense of $353.25 million for fiscal year 2025.
- SILICON LABORATORIES INC. showed an increase of +6.3% in R&D Expense compared to the prior fiscal year.
- SILICON LABORATORIES INC. reported Operating Income of -$70.54 million for fiscal year 2025.
- SILICON LABORATORIES INC. showed an increase of +57.4% in Operating Income compared to the prior fiscal year.
- SILICON LABORATORIES INC. reported Gross Profit of $456.98 million for fiscal year 2025.
- SILICON LABORATORIES INC. showed an increase of +46.4% in Gross Profit compared to the prior fiscal year.
- SILICON LABORATORIES INC. reported Shares Outstanding of 32.95 million shares for fiscal year 2025.
- SILICON LABORATORIES INC. showed an increase of +1.5% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: